Thirty-six of these reports describe a death by suicide or suspected suicide
All authors had access to the study data, critically reviewed the manuscript and approved the final version to be published
Currently in Phase III clinical trials, retatrutide is a triple agonist, meaning it targets three key metabolic pathways at once, GLP 1, GIP, and glucagon
Taste buds: cells, signals and synapses
Its primary source is found in food products of animal origin, including meat, milk, eggs, and more
The CDC guidance states that GLP-1 receptor agonists and SGLT2 inhibitors both improve blood sugar control and provide heart and kidney benefits